Technology News and Research

RSS

Surgeons to participate in Methodist Hospital's Pumps & Pipes symposia

Surgeons from The Methodist DeBakey Heart & Vascular Center along with scientists and engineers from two of the nation's largest industries - medicine and energy will take part in the first international Pumps & Pipes symposia in Doha, Qatar on April 28 to explore the synergies in moving oil and pumping blood.

29 Apr 2011

Journal Blood publishes MacroGenics' DART antibody technology preclinical data

MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART antibody technology.

29 Apr 2011

UMMS, RXi receive MLSC grant to develop RNAi therapeutics for ALS

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that the company's proposed research collaboration with the University of Massachusetts Medical School has been selected for Cooperative Research Matching Grant funding by the Massachusetts Life Sciences Center.

29 Apr 2011

Shielding body protects brain from “shell shocking” blast injuries

Stronger and tougher body armor to shield the chest, abdomen and back may be just what soldiers fighting in the Afghanistan and Iraq wars need to better protect their brains from mild injuries tied to so-called “shell shock,” results of a Johns Hopkins study in mice suggest. Such mild trauma, resulting from the initial shock of exploding mines, grenades and improvised explosive devices (IEDs) now accounts for more than 80 percent of all brain injuries among U.S. troops. Some 160,000 American veteran men and women are estimated to have sustained this kind of trauma.

29 Apr 2011

MorphoSys reaches second clinical milestone with OncoMed Pharmaceuticals

MorphoSys AG announced today that it has received a milestone payment from OncoMed Pharmaceuticals in connection with the FDA acceptance of an IND for a HuCAL-derived, fully human antibody. The antibody OMP-18R5, which targets the Wnt signaling pathway, will be evaluated in a Phase 1 trial in the US in patients with advanced solid tumors.

29 Apr 2011

Celanese EVA Performance Polymers, PSI partner to develop drug-eluting devices

Particle Sciences Inc., a leading pharmaceutical CRO, and Celanese EVA Performance Polymers, a leading supplier of ethylene vinyl acetate into pharmaceutical applications, are working together to streamline the development of drug-eluting devices.

29 Apr 2011

Terason releases new Breast Ultrasound system

Terason, the innovator and leader in laptop ultrasound technology today announced the release of the Terason t3200 Ultrasound System - Breast Series. This fully-functional, portable ultrasound system is the first of its kind designed specifically for the Breast Surgeon.

28 Apr 2011

Informed Medical Decisions announces acquisition of AccessDNA

Informed Medical Decisions, Inc. announced today it is acquiring AccessDNA, Inc., owner of Inherited Health, a leading online resource for individuals and families interested in understanding family history and hereditary disease risks.

28 Apr 2011

GE Healthcare reaches agreement to acquire Applied Precision

GE Healthcare, a unit of General Electric Company, today announced it has reached an agreement to acquire Applied Precision, Inc., a supplier of innovative cellular imaging technologies for the fast-growing cell biology and biomedical research sectors.

28 Apr 2011

AquaStar granted U.S. Patent for Portable Capillary Sensor technology used in Capwave ELISA platform

AquaStar Holdings, Inc. is pleased to announce that the United States Patent and Trademark Office has issued patent number 7,708,944 for the Ultra-Sensitive, Portable Capillary Sensor technology utilized by the Capwave Enzyme-Linked Immuno-Sorbent Assay (ELISA) platform.

28 Apr 2011

Bruker first quarter revenue increases 29% to $357.0 million

Bruker Corporation today reported financial results for the first quarter ended March 31, 2011.

28 Apr 2011

Leading pharmaceutical company, Flamel enter Micropump license agreement

Flamel Technologies announced today that it has entered into a license agreement with a leading specialty pharmaceutical company for development and commercialization of two molecules for pain indications.

28 Apr 2011

STAAR Surgical receives CE Mark approval for nanoFLEX Collamer IOL lens

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX Collamer Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT Injector System.

28 Apr 2011

Aetna first quarter operating earnings is $560.2 million for 2011

Aetna today announced first-quarter 2011 operating earnings of $560.2 million, or $1.43 per share, a per share increase of 46 percent over 2010.

28 Apr 2011

New microchip sensor can detect individual's respiratory rate

Researchers at Tyndall National Institute, UCC, Cork, have developed a microchip sensor that can detect a person's respiratory rate without any contact with the person under observation.

28 Apr 2011

Guided Therapeutics' cervical detection technology design, branding to be presented at ACOG

Guided Therapeutics, Inc., announced that it will present the new design and branding of its non-invasive and painless test for the early detection of cervical precancer at two upcoming international gynecology conferences.

28 Apr 2011

Northstar Healthcare acquires ownership interests in Texas based radiation therapy cancer treatment centers

Northstar Healthcare Inc. today announced that it entered into an agreement to acquire certain ownership interests in four physician owned radiation therapy cancer treatment centers from Dr. Chris Phan, a radiation oncologist. Dr. Phan is founder and Chief Executive Officer of Expert Oncology Network Solutions, LLC (EONS). EONS has been instrumental in developing and consulting with cancer centers across Texas.

28 Apr 2011

AstraZeneca introduces new CRESTOR and NEXIUM customer service websites

AstraZeneca announced today the launch of "click-to-chat" on CRESTOR.com and PurplePill.com. The new "click-to-chat" technology gives consumers an option to contact a live AstraZeneca customer service representative with just a click of a button.

28 Apr 2011

Softgels as effective as tablets in delivering folic acid

Folic acid, an essential vitamin formulated to be part of a multivitamin + DHA liquid softgel capsule, is absorbed and available within the body in amounts similar to folic acid formulated for solid tablets, according to a study presented in a late breaking session at the Experimental Biology (EB) 2011 annual meeting.

28 Apr 2011

GSN receives NIH grant for non-invasive prenatal test trial in genetic abnormalities

Gene Security Network announced today that they have received a $2 million grant from the National Institutes of Health to conduct a clinical trial applying Parental Support technology for non-invasive prenatal diagnosis.

28 Apr 2011